Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus

By Hussein Abd El-Aziz M.   Omar Nisereen M.   Sakr Hussein   Elsamanoudy Ayman Z.   Shaheen Dalia  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 3, 2011-03 ,pp. : 216-226

NRC Research Press

Access to resources Recommend Favorite

Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts

By Tamura M.   Chen Y.-J.   Howard E.F.   Tanner M.   Landon E.J.   Myers P.R.  

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 289-295

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of angiotensin II receptor antagonists

By White Michel   Racine Normand   Ducharme Anique   Champlain Jacques de  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1687-1701

Informa Healthcare

Access to resources Recommend Favorite

A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy

By Shah B.H.   Catt K.J.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 239-244

Elsevier

Access to resources Recommend Favorite

Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene

By  

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-01 ,pp. : 1062-1072

Bentham Science Publishers

Access to resources Recommend Favorite